vTv Therapeutics Pulls The Plug On Psoriasis Candidate; Cuts Workforce By 65%
vTv Therapeutics Inc (NASDAQ: VTVT) has
vTv Therapeutics Q3 EPS $(0.02), Same YoY
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last year.
vTv Therapeutics Granted U.S. Patent Titled ‘Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=4414&f=G&l=50&d=PTXT&p=89&S1=20210928&OS=20210928&RS=20210928
34 Stocks Moving In Friday’s Mid-Day Session
Gainers
ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares jumped 76.2% to $6.08.
vTv Therapeutics Stock Gains As Psoriasis Candidate Shows Favorable Safety Profile
​​​​​vTv Therapeutics Inc (NASDAQ:VTVT) announced the results of a multiple ascending dose study evaluating HPP737 in healthy adults. HPP737 is an…
22 Stocks Moving in Friday’s Pre-Market Session
Gainers
Focus Universal Inc. (NASDAQ: FCUV) rose 42% to $15.24 in pre-market trading. The company’s shares jumped around 65% over the previous month.
vTv Therapeutics Q2 EPS $(0.01) Up From $(0.08) YoY, Sales $9.00K
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.01) per share. This is a 87.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported $9.00 thousand in
Why Moderna, Bio-Path Holdings And vTv Therapeutics Are Moving Today
Moderna, Inc. (NASDAQ: MRNA), Bio-Path Holdings, Inc. (NASDAQ: BPTH) and vTv Therapeutics Inc.